المؤلفون: Qi Quan, Yixing Wang, Fenghua Wang, Dongsheng Zhang, Xiuxing Chen, Wenzhuo He, Bei Zhang, Guifang Guo

المصدر: Current Oncology, Vol 28, Iss 1, Pp 209-219 (2020)

مصطلحات موضوعية: pancreatic cancer, chemotherapy, nab-paclitaxel plus gemcitabine, mFOLFIRINOX, GEMOX, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/1718-7729/28/1/23Test; https://doaj.org/toc/1198-0052Test; https://doaj.org/toc/1718-7729Test

الوصول الحر: https://doaj.org/article/d67af574735b45e889928a5240beb83dTest

المؤلفون: Oh, Do-Youn, Cha, Yongjun, Choi, In-Sil, Yoon, So-Young, Choi, In Keun, Kim, Jee Hyun, Oh, Sang Cheul, Kim, Chang Duck, Kim, Jae Sun, Bang, Yung-Jue, Kim, Yeul Hong

المساهمون: Kim, Jee Hyun, Bang, Yung-Jue

مصطلحات موضوعية: ERLOTINIB PLUS GEMCITABINE, COOPERATIVE-ONCOLOGY-GROUP, ORAL S-1, SURGICAL RESECTION, CLINICAL BENEFIT, TRIAL, ADENOCARCINOMA, 5-FLUOROURACIL, CYTOTOXICITY, CAPECITABINE, Gemcitabine, S-1, Pancreatic cancer, Palliative

العلاقة: Cancer Chemotherapy and Pharmacology, Vol.65 No.3, pp.527-536; https://hdl.handle.net/10371/189883Test; 000273031400015; 2-s2.0-75549083878; 156551

الإتاحة: https://doi.org/10.1007/s00280-009-1059-9Test
https://hdl.handle.net/10371/189883Test

المؤلفون: Willis, SE, Winkler, C, Roudier, MP, Baird, T, Marco-Casanova, P, Jones, E, Rowe, P, Rodriguez-Canales, J, Angell, HK, Ng, FSL, Waring, PM, Hodgson, D, Ledermann, JA, Weberpals, J, Dean, E, Harrington, EA, Barrett, JC, Pierce, AJ, Leo, E, Jones, GN

المصدر: British Journal of Cancer (2021)

مصطلحات موضوعية: Oncology, SEROUS OVARIAN-CANCER, CELL LUNG-CANCER, PLATINUM-RESISTANT, PLUS GEMCITABINE, PARP INHIBITORS, CHEMOTHERAPY

وصف الملف: text

العلاقة: https://discovery.ucl.ac.uk/id/eprint/10137655/1/Ledermann_Retrospective%20analysis%20of%20Schlafen11%20%28SLFN11%29%20to%20predict%20the%20outcomes%20to%20therapies%20affecting%20the%20DNA%20damage%20response_VoR.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10137655Test/

الإتاحة: https://discovery.ucl.ac.uk/id/eprint/10137655/1/Ledermann_Retrospective%20analysis%20of%20Schlafen11%20%28SLFN11%29%20to%20predict%20the%20outcomes%20to%20therapies%20affecting%20the%20DNA%20damage%20response_VoR.pdfTest
https://discovery.ucl.ac.uk/id/eprint/10137655Test/

المؤلفون: Kato, Yoichiro, Zembutsu, Hitoshi, Takata, Ryo, Matsuura, Tomohiko, Kato, Renpei, Kanehira, Mitsugu, Iwasaki, Kazuhiro, Yamada, Noriyuki, Katagiri, Toyomasa, Sugai, Tamotsu, Fujioka, Tomoaki, Nakamura, Yusuke, Obara, Wataru

مصطلحات موضوعية: methotrexate, vinblastine, doxorubicin plus cisplatin, carboplatin plus gemcitabine, reverse transcription‑polymerase chain reaction, neoadjuvant chemotherapy, muscle invasive bladder cancer

العلاقة: http://repo.lib.tokushima-u.ac.jp/files/public/11/115665/20210208145522407881/ol_16_5_5775.pdfTest; http://repo.lib.tokushima-u.ac.jp/115665Test

الإتاحة: http://repo.lib.tokushima-u.ac.jp/115665Test

المؤلفون: Alberto Servetto, Antonio Santaniello, Fabiana Napolitano, Francesca Foschini, Roberta Marciano, Eleonora Mozzillo, Priscilla Cascetta, Anna Rita Amato, Maria Rosaria Augurio, Lucia Maresca, Pietro De Placido, Sabino De Placido, Luigi Formisano, Roberto Bianco

المصدر: Cancers; Volume 13; Issue 19; Pages: 4939

مصطلحات موضوعية: FOLFIRINOX, nab-paclitaxel plus gemcitabine, locally advanced pancreatic adenocarcinoma

وصف الملف: application/pdf

العلاقة: Cancer Therapy; https://dx.doi.org/10.3390/cancers13194939Test

الإتاحة: https://doi.org/10.3390/cancers13194939Test

المؤلفون: Ken-ichi Okada, MD, PhD, Manabu Kawai, MD, PhD, Seiko Hirono, MD, PhD, Motoki Miyazawa, MD, PhD, Yuji Kitahata, MD, PhD, Ryohei Kobayashi, MD, Masaki Ueno, MD, PhD, Shinya Hayami, MD, PhD, Toshio Shimokawa, PhD, Hiroki Yamaue, MD, PhD

المصدر: Current Therapeutic Research, Vol 93, Iss , Pp 100605- (2020)

مصطلحات موضوعية: Fatigue, Japanese herbal medicine, Nab-paclitaxel plus gemcitabine, Ninjin'yoeito, Supportive therapy, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S0011393X2030031XTest; https://doaj.org/toc/0011-393XTest

الوصول الحر: https://doaj.org/article/1e255b8d75634d299ec54f14292c0ebdTest

المؤلفون: Goldstein D., Von Hoff D. D., Chiorean E. G., Reni M., Tabernero J., Ramanathan R. K., Botteman M., Aly A., Margunato-Debay S., Lu B., Louis C. U., McGovern D., Lee C. K.

المساهمون: Goldstein, D., Von Hoff, D. D., Chiorean, E. G., Reni, M., Tabernero, J., Ramanathan, R. K., Botteman, M., Aly, A., Margunato-Debay, S., Lu, B., Louis, C. U., Mcgovern, D., Lee, C. K.

مصطلحات موضوعية: clinical variables, metastatic pancreatic cancer, nab-paclitaxel plus gemcitabine, nomogram, prognosis

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32541630; info:eu-repo/semantics/altIdentifier/wos/WOS:000549975300011; volume:49; issue:6; firstpage:744; lastpage:750; numberofpages:7; journal:PANCREAS; https://hdl.handle.net/20.500.11768/158319Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85087126173; https://journals.lww.com/pancreasjournal/fulltext/2020/07000/nomogram_for_estimating_overall_survival_in.5.aspxTest

الإتاحة: https://doi.org/20.500.11768/158319Test
https://doi.org/10.1097/MPA.0000000000001563Test
https://hdl.handle.net/20.500.11768/158319Test
https://journals.lww.com/pancreasjournal/fulltext/2020/07000/nomogram_for_estimating_overall_survival_in.5.aspxTest

المؤلفون: Belkouz, A., Wilmink, J. W., Mohammad, N. Haj, Hagendoorn, J., de Vos-Geelen, J., Dejong, C. H. C., Homs, M. Y. V., Koerkamp, B. Groot, van Gulik, T. M., van Oijen, M. G. H., Punt, C. J. A., Klumpen, H.

المصدر: Belkouz , A , Wilmink , J W , Mohammad , N H , Hagendoorn , J , de Vos-Geelen , J , Dejong , C H C , Homs , M Y V , Koerkamp , B G , van Gulik , T M , van Oijen , M G H , Punt , C J A & Klumpen , H 2020 , ' Advances in adjuvant therapy of biliary tract cancer : an overview of current clinical evidence based on phase II and III trials ' , Critical Reviews in Oncology/Hematology , vol. 151 , 102975 . ....

مصطلحات موضوعية: Cholangiocarcinoma, Biliary tract cancer, Adjuvant therapy, Neoadjuvant therapy, Chemotherapy, Chemoradiotherapy, PERIHILAR CHOLANGIOCARCINOMA, GEMCITABINE CHEMOTHERAPY, GALLBLADDER CARCINOMA, PROGNOSTIC-FACTORS, PLUS GEMCITABINE, RESECTION, CISPLATIN, SURVIVAL, S-1, OXALIPLATIN

الإتاحة: https://doi.org/10.1016/j.critrevonc.2020.102975Test
https://cris.maastrichtuniversity.nl/en/publications/43fdf78c-6018-442a-be27-67272f63fbb4Test

المؤلفون: Bei Zhang, Wenzhuo He, Dongsheng Zhang, Xiuxing Chen, Fenghua Wang, Yixing Wang, Qi Quan, Guifang Guo

المصدر: Current Oncology, Vol 28, Iss 23, Pp 209-219 (2021)
Current Oncology
Volume 28
Issue 1
Pages 23-219

مصطلحات موضوعية: medicine.medical_specialty, China, Paclitaxel, medicine.medical_treatment, pancreatic cancer, GemOx, Neutropenia, chemotherapy, Gastroenterology, Deoxycytidine, Article, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Pancreatic cancer, Albumins, medicine, Humans, GEMOX, 030212 general & internal medicine, Prospective Studies, nab-paclitaxel plus gemcitabine, RC254-282, Retrospective Studies, Chemotherapy, business.industry, Cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Gemcitabine, Oxaliplatin, Pancreatic Neoplasms, mFOLFIRINOX, 030220 oncology & carcinogenesis, business, Febrile neutropenia, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f4883dee949abd326de7691abc5eeb5Test
https://www.mdpi.com/1718-7729/28/1/23Test

المؤلفون: Bonomi, P D, Gandara, D, Hirsch, F R, Kerr, K M, Obasaju, C, Paz Ares, Luis Gonzaga, Bellomo, C, Bradley, J D, Bunn, P A, Culligan, M, Jett, J R, Kim, E S, Langer, C J, Natale, R B, Novello, S, Pérol, M, Ramalingam, S S, Reck, M, Reynolds, C H, Smit, E F, Socinski, M A, Spigel, D R, Vansteenkiste, J F, Wakelee, H, Thatcher, N

المساهمون: Fundación Lilly

مصطلحات موضوعية: GROWTH-FACTOR RECEPTOR, PHASE-III TRIAL, CLINICAL-PRACTICE GUIDELINES, CISPLATIN PLUS GEMCITABINE, OPEN-LABEL, STAGE IV, 1ST-LINE THERAPY, FOLLOW-UP, CETUXIMAB, CHEMOTHERAPY

العلاقة: https://doi.org/10.1093/annonc/mdy196Test.; Ann Oncol. 2018; 29(8):1701-1709.; http://hdl.handle.net/20.500.12105/6820Test; Annals of oncology : official journal of the European Society for Medical Oncology

الإتاحة: https://doi.org/20.500.12105/6820Test
https://doi.org/10.1093/annonc/mdy196Test
https://hdl.handle.net/20.500.12105/6820Test